Product
CT-P41
2 clinical trials
2 indications
Indication
Postmenopausal Women With OsteoporosisIndication
Healthy SubjectClinical trial
A Double-blind, Randomized, Active-controlled, Phase 3 Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety of CT-P41 and US-licensed Prolia in Postmenopausal Women With OsteoporosisStatus: Completed, Estimated PCD: 2023-05-18
Clinical trial
A Randomized, Double-blind, Two-arm, Parallel Group, Single-dose, Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male SubjectsStatus: Completed, Estimated PCD: 2022-10-20